Mereo Biopharma Group Plc Share Price Today
(NASDAQ: MREO)

Name: Mereo Biopharma Group Plc Share Price Today (NASDAQ: MREO) - Mereo Biopharma Group Plc Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Mereo Biopharma Group Plc share price is $2.53 & ₹220.03 as on 6 Mar 2025, 2.30 'hrs' IST

$2.53

▲

0.04

(1.61%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Mereo Biopharma Group Plc share price in Dollar and Rupees. Guide to invest in Mereo Biopharma Group Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mereo Biopharma Group Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Mereo Biopharma Group Plc share price movements

Today's Low: $2.37
Today's High: $2.54
$2.53
6.32%
Downside
Day's Volatility :6.51%
Upside
0.2%
52 Weeks Low: $2.32
52 Weeks High: $5.02
$2.53
8.3%
Downside
52 Weeks Volatility :53.78%
Upside
49.6%

Mereo Biopharma Group Plc (MREO) Returns

Period	Mereo Biopharma Group Plc	Index (Russel 2000)
3 Months	-28.24%	0.0%
6 Months	-43.79%	0.0%
1 Year	-33.24%	0.0%
3 Years	94.53%	-11.6%

Mereo Biopharma Group Plc (MREO) Key Statistics

in dollars & INR

Previous Close	$2.49
Open	$2.48
Today's High	$2.535
Today's Low	$2.37
Market Capitalization	$630.8M
Today's Volume	$326.6K
52 Week High	$5.02
52 Week Low	$2.32
Revenue TTM	$1000.0K
EBITDA	$-37.3M
Earnings Per Share (EPS)	$-0.25
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-48.47%

How to invest in Mereo Biopharma Group Plc Stock (MREO) from India?

It is very easy for Indian residents to invest directly in Mereo Biopharma Group Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mereo Biopharma Group Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mereo Biopharma Group Plc or MREO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mereo Biopharma Group Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mereo Biopharma Group Plc shares which would translate to 0.344 fractional shares of Mereo Biopharma Group Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mereo Biopharma Group Plc, in just a few clicks!

Returns in Mereo Biopharma Group Plc (MREO) for Indian investors in Rupees

The Mereo Biopharma Group Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Mereo Biopharma Group Plc investment value today

Current value as on today

₹72,791

Returns

₹27,209

(-27.21%)

Returns from Mereo Biopharma Group Plc Stock

₹32,172 (-32.17%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Mereo Biopharma Group Plc (MREO)

38%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Mereo Biopharma Group Plc Stock from India on INDmoney has increased by 38% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Mereo Biopharma Group Plc

HHG PLC
11.04%
Rubric Capital Management LP
9.87%
Rock Springs Capital Management LP
6.19%
Adage Capital Partners Gp LLC
5.62%
Mangrove Partners
5.57%
Deerfield Management Co
4.33%

Analyst Recommendation on Mereo Biopharma Group Plc

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Mereo Biopharma Group Plc(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Mereo Biopharma Group Plc Stock (MREO)

What analysts predicted

Upside of 185.38%

Target:

$7.22

Current:

$2.53

Insights on Mereo Biopharma Group Plc Stock (Ticker Symbol: MREO)

Price Movement
In the last 3 years, MREO stock has moved up by 116.5%
Decreasing Revenue
Revenue is down for the last 3 quarters, 8.79M → 361.1K (in $), with an average decrease of 63.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, -6.04M → -15.00M (in $), with an average decrease of 35.8% per quarter
MREO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 95.7%
Price to Sales
ForMREO every $1 of sales, investors are willing to pay $355.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Mereo Biopharma Group Plc Technicals Summary

Sell

Neutral

Buy

Mereo Biopharma Group Plc is currently in a neutral trading position according to technical analysis indicators.

Mereo Biopharma Group Plc (MREO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Mereo Biopharma Group Plc	-16.72%	-43.79%	-33.24%	94.53%	46.47%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Mereo Biopharma Group Plc	NA	NA	NA	-0.03	-0.48	-0.24	NA	0.51
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Mereo Biopharma Group Plc	Buy	$630.8M	46.47%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Mereo Biopharma Group Plc

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab (MPH-313), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumors. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism which is in Phase 2 trials. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), an antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; licensing agreement with AstraZeneca; and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize setrusumab. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, the United Kingdom.

Organization	Mereo Biopharma Group Plc
Employees	33
CEO	Dr. Denise Vera Scots-Knight Ph.D.
Industry	Biotechnology

Management People of Mereo Biopharma Group Plc

Name	Title
Dr. Denise Vera Scots-Knight Ph.D.	Co-Founder, CEO & Executive Director
Mr. Charles Edward Sermon	Co-Founder, General Counsel, Business Development & Company Secretary
Ms. Christine Fox CPA	Chief Financial Officer
Dr. John P. Richard M.B.A.	Co-Founder & Chief Business Officer
Dr. John A. Lewicki Ph.D.	Chief Scientific Officer
Dr. Jackie Parkin	Senior VP & Therapeutic Head
Ms. Alexandra Hughes-Wilson	Chief of Patient Access & Commercial Planning
Dr. Suba Krishnan	Senior Vice President of Clinical Development
Mr. Bo Kara	Senior VP and Head of Pharmaceutical Development & CMC

Important FAQs about investing in MREO Stock from India :

What is Mereo Biopharma Group Plc share price today?

Mereo Biopharma Group Plc share price today stands at $2.53, Open: $2.48 ; Previous Close: $2.49 ; High: $2.54 ; Low: $2.37 ; 52 Week High: $5.02 ; 52 Week Low: $2.32.

The stock opens at $2.48, after a previous close of $2.49. The stock reached a daily high of $2.54 and a low of $2.37, with a 52-week high of $5.02 and a 52-week low of $2.32.

Can Indians buy Mereo Biopharma Group Plc shares?

Yes, Indians can invest in the Mereo Biopharma Group Plc (MREO) from India.

With INDmoney, you can buy Mereo Biopharma Group Plc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Mereo Biopharma Group Plc at zero transaction cost.

How can I buy Mereo Biopharma Group Plc shares from India?

It is very easy to buy Mereo Biopharma Group Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mereo Biopharma Group Plc (MREO) be purchased?

Yes, you can buy fractional shares of Mereo Biopharma Group Plc with INDmoney app.

What are the documents required to start investing in Mereo Biopharma Group Plc stocks?

To start investing in Mereo Biopharma Group Plc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.